Cytometric analysis and clinical features in a Moroccan cohort with severe combined immunodeficiency.

Q3 Medicine
Aicha El Allam, Sara El Fakihi, Hicham Tahoune, Karima Sahmoudi, Houria Bousserhane, Youssef Bakri, Naima El Hafidi, Fouad Seghrouchni
{"title":"Cytometric analysis and clinical features in a Moroccan cohort with severe combined immunodeficiency.","authors":"Aicha El Allam,&nbsp;Sara El Fakihi,&nbsp;Hicham Tahoune,&nbsp;Karima Sahmoudi,&nbsp;Houria Bousserhane,&nbsp;Youssef Bakri,&nbsp;Naima El Hafidi,&nbsp;Fouad Seghrouchni","doi":"10.3233/HAB-211510","DOIUrl":null,"url":null,"abstract":"<p><p>Severe combined immunodeficiency (SCID) is a form of primary immunodeficiency disease (PID). It is characterized by a serious abnormality of the cellular and sometimes humoral system due to a deficiency in development of T cells, B cells and/or NK cells. The early diagnosis of SCID improves the prognosis. Typically, the initial consideration of SCID is made based on low lymphocyte counts. Notwithstanding, the heterogeneity of lymphocyte count presentation makes the diagnosis of SCID a significant challenge. The objective of this cross-sectional retrospective study was to analyze the lymphocyte subpopulation counts along with clinical manifestations within a Moroccan cohort diagnosed as SCID compared to children diagnosed with non-PID diseases. Thirty-five SCID confirmed patients were selected in the period between 2008 and 2018 and compared with non-PID patients. Results of peripheral blood T, B, and NK lymphocyte subpopulation counts were measured by flow cytometry for each SCID subtype. As expected, T cell count was less than 300 cells/μL in most patients with SCID (85.5%). Unexpectedly, significantly higher T cell counts were detected in some patients with a confirmed clinical diagnosis and family history of SCID. 5.7% of our SCID Moroccan cohort had T cell numbers in the range between 300 and 500 cells/μL. 8.7% of our SCID Moroccan cohort had T cell numbers higher than 500 cells/μL. Of the SCID subtypes, the proportion of SCID with B cell deficiencies was highly represented in our cohort. 71.4% of Moroccan SCID patients (25 out of 35 patients) were of T-B-subtype. Furthermore, 40% of the patients (14 out of 35 patients) had a T-B-NK+ profile and 31.4% had a T-B-NK- profile (11 out of 35 patients). The most common clinical manifestations observed in our SCID cohort were pneumonia, failure to thrive, candidiasis, diarrhea, bronchitis and urinary tract infections. Our results not only highlight the relatively frequent presence of atypical SCID in the Moroccan population with unexpectedly high T cell numbers, but also describes the incidence pattern of common SCID subtypes in Morocco. Physicians in Morocco may find this local region-specific difference in SCID important for making improved early diagnosis of this disease.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"30 2","pages":"67-77"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/HAB-211510","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Severe combined immunodeficiency (SCID) is a form of primary immunodeficiency disease (PID). It is characterized by a serious abnormality of the cellular and sometimes humoral system due to a deficiency in development of T cells, B cells and/or NK cells. The early diagnosis of SCID improves the prognosis. Typically, the initial consideration of SCID is made based on low lymphocyte counts. Notwithstanding, the heterogeneity of lymphocyte count presentation makes the diagnosis of SCID a significant challenge. The objective of this cross-sectional retrospective study was to analyze the lymphocyte subpopulation counts along with clinical manifestations within a Moroccan cohort diagnosed as SCID compared to children diagnosed with non-PID diseases. Thirty-five SCID confirmed patients were selected in the period between 2008 and 2018 and compared with non-PID patients. Results of peripheral blood T, B, and NK lymphocyte subpopulation counts were measured by flow cytometry for each SCID subtype. As expected, T cell count was less than 300 cells/μL in most patients with SCID (85.5%). Unexpectedly, significantly higher T cell counts were detected in some patients with a confirmed clinical diagnosis and family history of SCID. 5.7% of our SCID Moroccan cohort had T cell numbers in the range between 300 and 500 cells/μL. 8.7% of our SCID Moroccan cohort had T cell numbers higher than 500 cells/μL. Of the SCID subtypes, the proportion of SCID with B cell deficiencies was highly represented in our cohort. 71.4% of Moroccan SCID patients (25 out of 35 patients) were of T-B-subtype. Furthermore, 40% of the patients (14 out of 35 patients) had a T-B-NK+ profile and 31.4% had a T-B-NK- profile (11 out of 35 patients). The most common clinical manifestations observed in our SCID cohort were pneumonia, failure to thrive, candidiasis, diarrhea, bronchitis and urinary tract infections. Our results not only highlight the relatively frequent presence of atypical SCID in the Moroccan population with unexpectedly high T cell numbers, but also describes the incidence pattern of common SCID subtypes in Morocco. Physicians in Morocco may find this local region-specific difference in SCID important for making improved early diagnosis of this disease.

摩洛哥严重联合免疫缺陷队列的细胞分析和临床特征。
重度联合免疫缺陷(SCID)是原发性免疫缺陷疾病(PID)的一种形式。它的特点是由于T细胞、B细胞和/或NK细胞发育不足而导致细胞和有时体液系统的严重异常。SCID的早期诊断可改善预后。通常,对SCID的初步考虑是基于低淋巴细胞计数。尽管如此,淋巴细胞计数表现的异质性使得SCID的诊断面临重大挑战。本横断面回顾性研究的目的是分析诊断为SCID的摩洛哥队列中与诊断为非pid疾病的儿童相比的淋巴细胞亚群计数和临床表现。在2008年至2018年期间选择35例SCID确诊患者,并与非pid患者进行比较。流式细胞术检测各组SCID亚型外周血T、B、NK淋巴细胞亚群计数。正如预期的那样,大多数SCID患者(85.5%)的T细胞计数小于300个细胞/μL。出乎意料的是,在一些临床确诊和有SCID家族史的患者中检测到明显较高的T细胞计数。5.7%的SCID摩洛哥队列患者T细胞数量在300 - 500细胞/μL之间。8.7%的SCID摩洛哥队列患者T细胞数量高于500细胞/μL。在SCID亚型中,伴有B细胞缺陷的SCID比例在我们的队列中有很高的代表性。71.4%的摩洛哥SCID患者(35例患者中有25例)为t - b亚型。此外,40%的患者(35例患者中有14例)具有T-B-NK+特征,31.4%的患者具有T-B-NK-特征(35例患者中有11例)。在我们的SCID队列中观察到的最常见的临床表现是肺炎、生长不良、念珠菌病、腹泻、支气管炎和尿路感染。我们的研究结果不仅突出了非典型SCID在摩洛哥人群中相对频繁的存在,而且还描述了摩洛哥常见SCID亚型的发病率模式。摩洛哥的医生可能会发现SCID的这种局部区域特异性差异对改善这种疾病的早期诊断很重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Antibodies
Human Antibodies Medicine-Immunology and Allergy
CiteScore
3.50
自引率
0.00%
发文量
27
期刊介绍: Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信